Intrathecal meperidine attenuates shivering induced by spinal anesthesia

J. C. Chen, S. W. Hsu, L. H. Hu, Y. J. Hong, P. S. Tsai, T. C. Lin, C. F. Lin, T. T. Wei

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Shivering is a common and complex phenomenon that occurs in many patients during spinal anesthesia. Shivering can increase oxygen consumption up to 500 per cent which may be detrimental to patients with decreased myocardial reserve. The metabolic costs and cardiorespiratory consequences of shivering are important particularly for patients with anemia, coronary arterial disease, cardiopulmonary insufficient, debilitated status or are elderly. We studied whether intrathecal meperidine could prevent shivering after spinal anesthesia. 60 patients with ASA class I-II were divided into intrathecal meperidine group (Group I) (n = 30) and control group (Group II) (n = 30). Group I received spinal tetracaine 12-16 mg with meperidine 0.2 mg/kg and Group II received spinal tetracaine 12-16 mg without meperidine. During operation the highest level of spinal anesthesia, ambient and rectal temperatures, blood pressure (BP) and heart rate (HR), presence or absence of shivering, intensity of shivering in both groups were recorded. Close observation for side effects was given post-operatively. There was a significant reduction (p < .005) in incidence of shivering in group I patients (16.7%) when compared with group II (56.7%). There was no or less side effects observed with other neuraxial opioids except nausea. We concluded that intrathecal meperidine could suppress shivering induced by spinal anesthesia.

Original languageEnglish
Pages (from-to)19-24
Number of pages6
JournalMa zui xue za zhi = Anaesthesiologica Sinica
Volume31
Issue number1
Publication statusPublished - Mar 1 1993
Externally publishedYes

Fingerprint

Shivering
Meperidine
Spinal Anesthesia
Tetracaine
Oxygen Consumption
Nausea
Opioid Analgesics
Coronary Disease
Anemia
Heart Rate
Observation
Blood Pressure
Costs and Cost Analysis
Control Groups
Temperature
Incidence

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Chen, J. C., Hsu, S. W., Hu, L. H., Hong, Y. J., Tsai, P. S., Lin, T. C., ... Wei, T. T. (1993). Intrathecal meperidine attenuates shivering induced by spinal anesthesia. Ma zui xue za zhi = Anaesthesiologica Sinica, 31(1), 19-24.

Intrathecal meperidine attenuates shivering induced by spinal anesthesia. / Chen, J. C.; Hsu, S. W.; Hu, L. H.; Hong, Y. J.; Tsai, P. S.; Lin, T. C.; Lin, C. F.; Wei, T. T.

In: Ma zui xue za zhi = Anaesthesiologica Sinica, Vol. 31, No. 1, 01.03.1993, p. 19-24.

Research output: Contribution to journalArticle

Chen, JC, Hsu, SW, Hu, LH, Hong, YJ, Tsai, PS, Lin, TC, Lin, CF & Wei, TT 1993, 'Intrathecal meperidine attenuates shivering induced by spinal anesthesia', Ma zui xue za zhi = Anaesthesiologica Sinica, vol. 31, no. 1, pp. 19-24.
Chen, J. C. ; Hsu, S. W. ; Hu, L. H. ; Hong, Y. J. ; Tsai, P. S. ; Lin, T. C. ; Lin, C. F. ; Wei, T. T. / Intrathecal meperidine attenuates shivering induced by spinal anesthesia. In: Ma zui xue za zhi = Anaesthesiologica Sinica. 1993 ; Vol. 31, No. 1. pp. 19-24.
@article{471d1f0ace334b83ba51bf6fdf817b8d,
title = "Intrathecal meperidine attenuates shivering induced by spinal anesthesia",
abstract = "Shivering is a common and complex phenomenon that occurs in many patients during spinal anesthesia. Shivering can increase oxygen consumption up to 500 per cent which may be detrimental to patients with decreased myocardial reserve. The metabolic costs and cardiorespiratory consequences of shivering are important particularly for patients with anemia, coronary arterial disease, cardiopulmonary insufficient, debilitated status or are elderly. We studied whether intrathecal meperidine could prevent shivering after spinal anesthesia. 60 patients with ASA class I-II were divided into intrathecal meperidine group (Group I) (n = 30) and control group (Group II) (n = 30). Group I received spinal tetracaine 12-16 mg with meperidine 0.2 mg/kg and Group II received spinal tetracaine 12-16 mg without meperidine. During operation the highest level of spinal anesthesia, ambient and rectal temperatures, blood pressure (BP) and heart rate (HR), presence or absence of shivering, intensity of shivering in both groups were recorded. Close observation for side effects was given post-operatively. There was a significant reduction (p < .005) in incidence of shivering in group I patients (16.7{\%}) when compared with group II (56.7{\%}). There was no or less side effects observed with other neuraxial opioids except nausea. We concluded that intrathecal meperidine could suppress shivering induced by spinal anesthesia.",
author = "Chen, {J. C.} and Hsu, {S. W.} and Hu, {L. H.} and Hong, {Y. J.} and Tsai, {P. S.} and Lin, {T. C.} and Lin, {C. F.} and Wei, {T. T.}",
year = "1993",
month = "3",
day = "1",
language = "English",
volume = "31",
pages = "19--24",
journal = "Asian Journal of Anesthesiology",
issn = "2468-824X",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

TY - JOUR

T1 - Intrathecal meperidine attenuates shivering induced by spinal anesthesia

AU - Chen, J. C.

AU - Hsu, S. W.

AU - Hu, L. H.

AU - Hong, Y. J.

AU - Tsai, P. S.

AU - Lin, T. C.

AU - Lin, C. F.

AU - Wei, T. T.

PY - 1993/3/1

Y1 - 1993/3/1

N2 - Shivering is a common and complex phenomenon that occurs in many patients during spinal anesthesia. Shivering can increase oxygen consumption up to 500 per cent which may be detrimental to patients with decreased myocardial reserve. The metabolic costs and cardiorespiratory consequences of shivering are important particularly for patients with anemia, coronary arterial disease, cardiopulmonary insufficient, debilitated status or are elderly. We studied whether intrathecal meperidine could prevent shivering after spinal anesthesia. 60 patients with ASA class I-II were divided into intrathecal meperidine group (Group I) (n = 30) and control group (Group II) (n = 30). Group I received spinal tetracaine 12-16 mg with meperidine 0.2 mg/kg and Group II received spinal tetracaine 12-16 mg without meperidine. During operation the highest level of spinal anesthesia, ambient and rectal temperatures, blood pressure (BP) and heart rate (HR), presence or absence of shivering, intensity of shivering in both groups were recorded. Close observation for side effects was given post-operatively. There was a significant reduction (p < .005) in incidence of shivering in group I patients (16.7%) when compared with group II (56.7%). There was no or less side effects observed with other neuraxial opioids except nausea. We concluded that intrathecal meperidine could suppress shivering induced by spinal anesthesia.

AB - Shivering is a common and complex phenomenon that occurs in many patients during spinal anesthesia. Shivering can increase oxygen consumption up to 500 per cent which may be detrimental to patients with decreased myocardial reserve. The metabolic costs and cardiorespiratory consequences of shivering are important particularly for patients with anemia, coronary arterial disease, cardiopulmonary insufficient, debilitated status or are elderly. We studied whether intrathecal meperidine could prevent shivering after spinal anesthesia. 60 patients with ASA class I-II were divided into intrathecal meperidine group (Group I) (n = 30) and control group (Group II) (n = 30). Group I received spinal tetracaine 12-16 mg with meperidine 0.2 mg/kg and Group II received spinal tetracaine 12-16 mg without meperidine. During operation the highest level of spinal anesthesia, ambient and rectal temperatures, blood pressure (BP) and heart rate (HR), presence or absence of shivering, intensity of shivering in both groups were recorded. Close observation for side effects was given post-operatively. There was a significant reduction (p < .005) in incidence of shivering in group I patients (16.7%) when compared with group II (56.7%). There was no or less side effects observed with other neuraxial opioids except nausea. We concluded that intrathecal meperidine could suppress shivering induced by spinal anesthesia.

UR - http://www.scopus.com/inward/record.url?scp=0027568668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027568668&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 19

EP - 24

JO - Asian Journal of Anesthesiology

JF - Asian Journal of Anesthesiology

SN - 2468-824X

IS - 1

ER -